BeStock  
Stocks › Biotechnology › URGN

UroGen Pharma Ltd URGN

US equityMarket cap rank #2953Biotechnology
$27.65 −$4.08 (-12.86%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.65 0.00%
Open$31.15
Prev close$31.73
Day range$27.57 – $31.90
Volume2.40M
Market cap$1.36B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$62.20+125.0% vs. price
  • Buy 100%
Low $56.00Now $27.65Avg $62.20High $75.00

Recent rating changes

The last 20 actions on file set price targets from $42.00 to $75.00, averaging $62.10.

DateFirmRatingTarget
5 Nov 2026 Piper Sandler BUY $58.00
5 Nov 2026 Ladenburg Thalmann BUY $62.00
5 Nov 2026 H.C. Wainwright BUY $75.00
5 Nov 2026 Oppenheimer BUY $60.00
4 Nov 2026 Guggenheim BUY $56.00
3 Nov 2026 H.C. Wainwright BUY $75.00
28 Oct 2026 Oppenheimer BUY $60.00
19 Oct 2026 Guggenheim BUY $58.00
19 Oct 2026 H.C. Wainwright BUY $75.00
21 Aug 2026 H.C. Wainwright BUY $75.00
20 Aug 2026 H.C. Wainwright BUY $75.00
11 Aug 2026 H.C. Wainwright BUY $75.00
6 Aug 2026 H.C. Wainwright BUY $75.00
6 Aug 2026 Oppenheimer BUY $60.00
5 Aug 2026 TD Cowen BUY $60.00
5 Aug 2026 Goldman Sachs HOLD $48.00
5 Aug 2026 Guggenheim BUY $58.00
21 Jul 2026 Guggenheim BUY $42.00
20 Jul 2026 TD Cowen BUY $50.00
16 Jul 2026 H.C. Wainwright BUY $45.00

Discussion

No comments yet — be the first to weigh in on URGN.

Sign in to join the discussion.

Scroll to Top